rs17470454
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_032122.5(DTNBP1):c.814C>T(p.Pro272Ser) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.049 in 1,613,910 control chromosomes in the GnomAD database, including 2,473 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_032122.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DTNBP1 | NM_032122.5 | c.814C>T | p.Pro272Ser | missense_variant, splice_region_variant | 10/10 | ENST00000344537.10 | NP_115498.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DTNBP1 | ENST00000344537.10 | c.814C>T | p.Pro272Ser | missense_variant, splice_region_variant | 10/10 | 1 | NM_032122.5 | ENSP00000341680.6 |
Frequencies
GnomAD3 genomes AF: 0.0416 AC: 6328AN: 152210Hom.: 201 Cov.: 33
GnomAD3 exomes AF: 0.0425 AC: 10675AN: 251402Hom.: 402 AF XY: 0.0423 AC XY: 5747AN XY: 135910
GnomAD4 exome AF: 0.0498 AC: 72806AN: 1461582Hom.: 2272 Cov.: 31 AF XY: 0.0486 AC XY: 35302AN XY: 727112
GnomAD4 genome AF: 0.0415 AC: 6328AN: 152328Hom.: 201 Cov.: 33 AF XY: 0.0429 AC XY: 3198AN XY: 74502
ClinVar
Submissions by phenotype
not provided Benign:5
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 09, 2018 | This variant is associated with the following publications: (PMID: 17000706) - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 12, 2014 | p.Pro272Ser in exon 10 of DTNBP1: This variant is not expected to have clinical significance because it has been identified in 5% (437/8600) of European America n chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.ed u/EVS/; dbSNP rs17470454). - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 10, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at